Surgery Partners Inc

Surgery Partners Inc(SGRY)の株式分析

$15.750

-0.148 (-0.94%)終値時点

Loading chart…
高値
16.160
始値
15.790
出来高加重平均価格
15.86
出来高
3.33M
時価総額
3.09B
安値
15.660
売買代金
52.84M
EV/EBITDA(TTM)
10.45

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals.

surgerypartners.com

AI分析 of Surgery Partners Inc (SGRY)

買い

Surgery Partners Inc is a good buy right now due to its current price of $14.61, which is significantly below the median analyst price target of $19, indicating a potential upside of 35.9%. Additionally, the stock has shown positive momentum with a 5-day change of +5.18% and a Relative Strength Index (RSI) of 63.79, suggesting it is gaining strength. However, investors should be cautious of the company's substantial debt of $4 billion, which poses a risk to its financial stability.

アナリスト評価(9)

上値余地 +66.98%
買い
4 買い
4 中立
1 売り
現在: 15.75
安値
18.00
平均
26.30
高値
36.00

JPMorgan

2026-09-14

目標株価

$15

中立

RBC Capital

2026-08-11

目標株価

$19

アウトパフォーム

TD Cowen

2026-08-11

目標株価

$19

買い

Cantor Fitzgerald

2026-08-11

目標株価

$18

オーバーウェイト

Jefferies

2026-05-06

目標株価

$17

買い

バリュエーション指標

Surgery Partners Inc(SGRY)の現在の予想PERは18.90で、5年平均は74.10です。

予想PER

適正
5年平均 P/E
74.10
現在のP/E
18.90
割高
212.09
割安
-63.89

予想EV/EBITDA

割安
5年平均 EV/EBITDA
15.69
現在のEV/EBITDA
10.45
割高
19.96
割安
11.42

予想PSR

適正
5年平均 P/S
1.09
現在のP/S
0.74
割高
1.50
割安
0.68

Alphio AI による SGRY の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%SGRY

$22.84

シナリオ価格

基

基本

基本 · 50%SGRY

$21.90

シナリオ価格

弱

弱気

弱気 · 25%SGRY

$21.04

シナリオ価格

SGRY を保有するクジラ

J

Jaunty Global Limited

+ を保有SGRY

+1.65%

3か月リターン

D

Davidson Kempner Capital Management LP

+ を保有SGRY

-8.46%

3か月リターン

P

Pentwater Capital Management LP

+ を保有SGRY

-9.06%

3か月リターン

イベントタイムライン

2026-10-18 (ET)

21:00:00

Chewy Short Interest Surges to 91.3%

2026-08-23 (ET)

00:00:00

Charter Communications Short Interest Rises to 32.4%

2026-08-10 (ET)

17:00:00

Stocks Open Lower as Middle East Uncertainty Grows

12:30:00

Major Averages Mixed at Open Amid Middle East Uncertainty

08:00:00

Company Reaffirms 2026 Revenue Outlook of $3.35B to $3.45B

ニュース

SGRY のよくある質問 — Alphio AI が回答

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

Surgery Partners Inc is a good buy right now due to its current price of $14.61, which is significantly below the median analyst price target of $19, indicating a potential upside of 35.9%. Additionally, the stock has shown positive momentum with a 5-day change of +5.18% and a Relative Strength Index (RSI) of 63.79, suggesting it is gaining strength. However, investors should be cautious of the company's substantial debt of $4 billion, which poses a risk to its financial stability.

9 analysts cover SGRY: 4 rate it Buy, 4 Hold and 1 Sell. The average price target is 26.30.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める